1. al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N,
Khoja T: High prevalence of overweight and obesity in Saudi
Arabia. Int J Obes Relat Metab Disord 1996, 20(11):547-552.
2. al-Nuaim AR, al-Rubeaan K, al-Mazrou Y, al-Attas O, al-Daghari N:
Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological
study. Int J Cardiol 1996, 54(1):41-49.
3. al-Shammari SA, Ali M, al-Shammari A, al-Maatouq M, Tennier A,
Armstrong K: Blood lipid concentrations and other cardiovascular
risk factors among Saudis. Fam Pract 1994, 11(2):153-158.
4. Al-Dawood KM: Pattern of smoking among parents of schoolboys.
Saudi Med J 2000, 21(8):735-739.
5. Al-Nozha MM, Arafah MR, Al-Mazrou YY, AL-Maatouq MA, Khan NB,
Khalil MZ, Al-Khadra AH, Al-Marzouki K, Abdullah MA, Al-Harthi SS,
Al-Shahid MS, Nouh MS, Al-Mobeireek A: Coronary Artery Disease
in Saudi Arabia. Saudi Med J 2004, 25(9):1165-1171.
6. Al-Turki YA: Overview of chronic diseases in the Kingdom of
Saudi Arabia. Saudi Med J 2000, 21(5):499-500.
7. Al-Nuaim AR: Prevalence of glucose intolerance in urban and
rural communities in Saudi Arabia. Diabet Med 1997,
14(7):595-602.
8. Baron AD: Impaired glucose tolerance as a disease. Am J Cardiol
2001, 88(6A):16H-19H.
9. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J: Diabetes,
asymptomatic hyperglycemia, and 22-year mortality
in black and white men. The Chicago Heart Association
Detection Project in Industry Study. Diabetes Care 1997,
20(2):163-169.
10. Jackson CA, Yudkin JS, Forrest RD: A comparison of the relationships
of the glucose tolerance test and the glycated haemoglobin
assay with diabetic vascular disease in the community.
The Islington Diabetes Survey. Diabetes Res Clin Pract 1992,
17(2):111-123.
11. [No authors listed]: Report of the Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus. Diabetes care
1997, 20(7):1183-1197.
12. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R, Baltimore
Longitudinal Study of Aging: The natural history of progression
from normal glucose tolerance to type 2 diabetes in the Baltimore
Longitudinal study of aging. Diabetes 2003,
52(6):1475-1484.
13. Kannel WB, McGee DL: Diabetes and cardiovascular disease:
The Framingham Study. JAMA 1979, 241(19):2035-2038.
14. Gu K, Cowie CC, Harris MI: Mortality in adults with and without
diabetes in a national cohort of the US population, 1971–
1993. Diabetes Care 1998, 21(7):1138-1145.
15. Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, Mac-
Mahon S, Asia Pacific Cohort Studies Collaboration: The effects of
diabetes on the risks of major cardiovascular diseases and
death in the Asia-Pacific region. Diabetes Care 2003,
26(2):360-366.
16. Kannel WB: Lipids, diabetes, and coronary heart disease:
insights from the Framingham Study. Am Heart J 1985,
110(5):1100-1107.
17. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other
risk factors, and 12-yr cardiovascular mortality for men
screened in the Multiple Risk Factor Intervention Trial. Diabetes
Care 1993, 16(2):434-444.
18. Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener
JS, Brancati FL, Orchard TJ, O'Leary DH, Savage PJ, Cardiovascular
Health Study: Prevalence of clinical and isolated
subclinical cardiovascular disease in older adults with glucose
disorders: the Cardiovascular Health Study. Diabetes
Care 2001, 24(7):1233-1239.
19. Fisman EZ, Motro M, Tenenbaum A, Boyko V, Mandelzweig L, Behar
S: Impaired fasting glucose concentrations in nondiabetic
patients with ischemic heart disease: a marker for a worse
prognosis. Am Heart J 2001, 141(3):485-490.
20. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah
MR, Khalil MZ, Al-Khadra A, Al-Marzouki K, Nouh MS, Abdullah M,
Attas O, Al-Shahid MS, Al-Mobeireek A: Diabetes mellitus in
Saudi Arabia. Saudi Med J 2004, 25(11):1603-1610.
21. Lonnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of
the obese (ob) gene in adipose tissue of human obese subjects.
Nat Med 1995, 1(9):950-953.
22. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW,
Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, et al.:
Serum immunoreactive-leptin concentrations in normalweight
and obese humans. N Engl J Med 1996, 334(5):292-295.
23. Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar
S: Serum leptin is elevated in Saudi Arabian patients with
metabolic syndrome and coronary artery disease. Diabet Med
2003, 20(10):832-837.
24. American Diabetes Association: Diagnosis and classification of
diabetes mellitus. Diabetes Care 2004, 27(Suppl 1):S5-S10.
25. Matthews DR, Rudenski AS, Naylor BA, Treacher DF, Turner RC:
Homeostasis model assessment: insulin resistance and betacell
function from fasting plasma glucose and insulin concentrations
in man. Diabetologia 1985, 28(7):412-419.
26. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular
risk factors in confirmed prediabetic individuals.
Does the clock for coronary heart disease start ticking
before the onset of clinical diabetes? JAMA 1990,
263(21):2893-2898.
27. Medalie JH, Papier CM, Goldbourt U, Herman JB: Major factors in
the development of diabetes mellitus in 10,000 men. Arch
Intern Med 1975, 135(6):811-817.
28. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease
risk factors prior to the diagnosis of impaired glucose
tolerance and non-insulin-dependent diabetes mellitus in a
community of older adults. Am J Epidemiol 1990, 131(3):443-453.
29. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history
of insulin secretory dysfunction and insulin resistance in the
pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999,
104(6):787-794.
30. Pyorala M, Miettinen H, Laakso M, Pyorala K: Hyperinsulinemia
and the risk of stroke in healthy middle-aged men: the 22-
year follow-up results of the Helsinki Policemen Study. Stroke
1998, 29(9):1860-1866.
31. Jarrett RJ: Why is insulin not a risk factor for coronary heart
disease? Diabetologia 1994, 37(9):945-947.
32. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M,
Uusitupa M: Carotid artery intima – media thickness in elderly
patients with NIDDM and in nondiabetic subjects. Stroke
1996, 27(11):1986-1992.
33. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G:
Hyperinsulinaemia is not a major coronary risk factor in elderly
men: The study of men born in 1913. Diabetologia 1992,
35(8):766-770.
34. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted
syndrome responsible for NIDDM, obesity, hypertension,
dyslipidemia and atherosclerotic cardiovascular disease. Diabetes
1991, 14(3):173-194.
35. Reaven GM, Laws A: Insulin resistance, compensatory hyperinsulinaemia,
and coronary heart disease. Diabetologia 1994,
37(9):948-952.
36. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of
intra-abdominal fat accumulation to the impairment of glucose
and lipid metabolism in human obesity. Metabolism 1987,
36(1):54-59.
37. Castracane VD, Henson MC: When did leptin become a reproductive
hormone? Semin Reprod Med 2002, 20(2):89-92.
38. Alexander CM, Landsman PB, Teutsch SM: Diabetes mellitus,
impaired fasting glucose, atherosclerotic risk factors, and
prevalence of coronary heart disease. Am J Cardiol 2000,
86(9):897-902.
39. Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan
PF, Liao EY: Relationship of serum leptin with age, body
weight, body mass index, and bone mineral density in
healthy mainland Chinese women. Clin Chim Acta 2005, 351(1–
2):161-168.
40. Maugeri D, Bonanno MR, Speciale S, Santangelo A, Lentini A, Russo
MS, Calanna A, Malaguarnera M, Motta M, Testai' M, Panebianco P:
The leptin, a new hormone of adipose tissue: clinical findings
and perspectives in geriatrics. Arch Gerontol Geriatr 2002,
34(1):47-54.
41. Leonhardt W, Horn R, Brabant G, Breidert M, Temelkova-Kurktschiev
T, Fucker K, Hanefeld M: Relation of free and specifically
bound leptin to insulin secretion in patients with impaired
glucose tolerance (IGT). Exp Clin Endocrinol Diabetes 1997,
107(1):46-52.
42. Asakawa H, Tokunaga K, Kawakami F: Relationship of leptin level
with metabolic disorders and hypertension in Japanese type
2 diabetes mellitus patients. J Diabetes Complications 2001,
15(2):57-62.
43. Couillard C, Mauriege P, Prud'homme D, Nadeau A, Tremblay A,
Bouchard C, Despres JP: Plasma leptin concentrations: gender
differences and associations with metabolic risk factors for
cardiovascular disease. Diabetologia 1997, 40(10):1178-1184.
44. Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader
DJ, Kimmel SE: Plasma leptin levels are associated with coronary
atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab
2004, 89(8):3872-3878.
45. Lichnovska R, Gwozdziewiczova A, Hrebicek J: Gender differences
in factors influencing insulin resistance in elderly hyperlipemic
non-diabetic subjects. Cardiovasc Diabetol 2002, 1:4.
46. Adamia N, Virsaladze D, Charkviani N, Skhirtladze M, Khutsishvili M:
Effect of metformin therapy on plasma adiponectin and leptin
levels in obese and insulin resistant postmenopausal
females with type 2 diabetes. Georgian Med News 2007:52-55.
47. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD: Lean, nondiabetic
Asian Indians have decreased insulin sensitivity and insulin
clearance, and raised leptin compared to Caucasians and
Chinese subjects. Int J Obes Relat Metab Disord 2003,
27(7):784-789.
48. Lofgren I, Herron K, Zern T, West K, Patalay M, Shachter NS, Koo
SI, Fernandez ML: Waist circumference is a better predictor
than body mass index of coronary heart disease risk in overweight
premenopausal women. J Nutr 2004, 134(5):1071-1076.
49. Haffner SM, Gingerich RL, Miettinen H, Stern MP: Leptin concentrations
in relation to overall adiposity and regional body fat
distribution in Mexican Americans. Int J Obes Relat Metab Disord
1996, 20(10):904-908.
50. Kafulafula G, Moodley J: Leptin levels in the obese African parturient.
J Obstet Gynaecol 2001, 21(3):228-231.